nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Estramustine—prostate cancer	0.398	1	CiPCiCtD
Thiotepa—urinary bladder cancer—prostate cancer	0.292	1	CtDrD
Thiotepa—CYP3A4—prostate cancer	0.077	1	CbGaD
Thiotepa—CYP2B6—Estrone—prostate cancer	0.0208	0.146	CbGbCtD
Thiotepa—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0203	0.142	CbGbCtD
Thiotepa—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0186	0.13	CbGbCtD
Thiotepa—CYP3A4—Bicalutamide—prostate cancer	0.0107	0.0747	CbGbCtD
Thiotepa—CYP3A4—Estramustine—prostate cancer	0.00994	0.0694	CbGbCtD
Thiotepa—CYP3A4—Flutamide—prostate cancer	0.00886	0.0619	CbGbCtD
Thiotepa—CYP3A4—Abiraterone—prostate cancer	0.00886	0.0619	CbGbCtD
Thiotepa—CYP3A4—Cabazitaxel—prostate cancer	0.00655	0.0458	CbGbCtD
Thiotepa—CYP3A4—Estrone—prostate cancer	0.0064	0.0447	CbGbCtD
Thiotepa—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00571	0.0399	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—prostate cancer	0.00533	0.0373	CbGbCtD
Thiotepa—CYP3A4—Conjugated Estrogens—prostate cancer	0.00419	0.0293	CbGbCtD
Thiotepa—CYP3A4—Mitoxantrone—prostate cancer	0.00381	0.0266	CbGbCtD
Thiotepa—CYP3A4—Estradiol—prostate cancer	0.00368	0.0257	CbGbCtD
Thiotepa—CYP3A4—Prednisone—prostate cancer	0.00316	0.0221	CbGbCtD
Thiotepa—CYP3A4—Etoposide—prostate cancer	0.0024	0.0168	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—prostate cancer	0.0022	0.0154	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—prostate cancer	0.00164	0.0114	CbGbCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	1.68e-05	0.000792	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.67e-05	0.000788	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.66e-05	0.000783	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.64e-05	0.000773	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1A1—prostate cancer	1.63e-05	0.000769	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.62e-05	0.000762	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HAO1—prostate cancer	1.61e-05	0.000759	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A1—prostate cancer	1.61e-05	0.000759	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.6e-05	0.000755	CbGpPWpGaD
Thiotepa—Pneumonia—Doxorubicin—prostate cancer	1.59e-05	0.000234	CcSEcCtD
Thiotepa—Gastrointestinal pain—Etoposide—prostate cancer	1.59e-05	0.000234	CcSEcCtD
Thiotepa—Nervous system disorder—Docetaxel—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.58e-05	0.000747	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.58e-05	0.000747	CbGpPWpGaD
Thiotepa—Thrombocytopenia—Docetaxel—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—Rash—Estradiol—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—Dermatitis—Estradiol—prostate cancer	1.58e-05	0.000233	CcSEcCtD
Thiotepa—Anaemia—Prednisone—prostate cancer	1.58e-05	0.000232	CcSEcCtD
Thiotepa—Confusional state—Capecitabine—prostate cancer	1.58e-05	0.000232	CcSEcCtD
Thiotepa—Tachycardia—Docetaxel—prostate cancer	1.58e-05	0.000232	CcSEcCtD
Thiotepa—Headache—Estradiol—prostate cancer	1.57e-05	0.000231	CcSEcCtD
Thiotepa—Skin disorder—Docetaxel—prostate cancer	1.57e-05	0.000231	CcSEcCtD
Thiotepa—Agitation—Prednisone—prostate cancer	1.57e-05	0.000231	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.56e-05	0.000736	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.56e-05	0.000736	CbGpPWpGaD
Thiotepa—Renal failure—Doxorubicin—prostate cancer	1.55e-05	0.000229	CcSEcCtD
Thiotepa—Infection—Capecitabine—prostate cancer	1.55e-05	0.000229	CcSEcCtD
Thiotepa—Urticaria—Etoposide—prostate cancer	1.54e-05	0.000227	CcSEcCtD
Thiotepa—Haemoglobin—Epirubicin—prostate cancer	1.54e-05	0.000227	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—prostate cancer	1.54e-05	0.000227	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—prostate cancer	1.54e-05	0.000227	CcSEcCtD
Thiotepa—Anorexia—Docetaxel—prostate cancer	1.54e-05	0.000227	CcSEcCtD
Thiotepa—Body temperature increased—Etoposide—prostate cancer	1.54e-05	0.000226	CcSEcCtD
Thiotepa—Abdominal pain—Etoposide—prostate cancer	1.54e-05	0.000226	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—prostate cancer	1.54e-05	0.000226	CcSEcCtD
Thiotepa—Nervous system disorder—Capecitabine—prostate cancer	1.53e-05	0.000226	CcSEcCtD
Thiotepa—Haemorrhage—Epirubicin—prostate cancer	1.53e-05	0.000226	CcSEcCtD
Thiotepa—Thrombocytopenia—Capecitabine—prostate cancer	1.53e-05	0.000225	CcSEcCtD
Thiotepa—Tachycardia—Capecitabine—prostate cancer	1.53e-05	0.000225	CcSEcCtD
Thiotepa—Skin disorder—Capecitabine—prostate cancer	1.52e-05	0.000224	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.52e-05	0.000716	CbGpPWpGaD
Thiotepa—Urinary tract disorder—Epirubicin—prostate cancer	1.52e-05	0.000223	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—prostate cancer	1.51e-05	0.000222	CcSEcCtD
Thiotepa—Connective tissue disorder—Epirubicin—prostate cancer	1.51e-05	0.000222	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—prostate cancer	1.5e-05	0.000221	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.5e-05	0.000706	CbGpPWpGaD
Thiotepa—Hepatobiliary disease—Doxorubicin—prostate cancer	1.5e-05	0.00022	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—prostate cancer	1.49e-05	0.000219	CcSEcCtD
Thiotepa—Anorexia—Capecitabine—prostate cancer	1.49e-05	0.000219	CcSEcCtD
Thiotepa—Nausea—Estradiol—prostate cancer	1.49e-05	0.000219	CcSEcCtD
Thiotepa—Vomiting—Mitoxantrone—prostate cancer	1.49e-05	0.000219	CcSEcCtD
Thiotepa—Convulsion—Prednisone—prostate cancer	1.48e-05	0.000218	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—prostate cancer	1.48e-05	0.000217	CcSEcCtD
Thiotepa—Hypertension—Prednisone—prostate cancer	1.47e-05	0.000217	CcSEcCtD
Thiotepa—Rash—Mitoxantrone—prostate cancer	1.47e-05	0.000217	CcSEcCtD
Thiotepa—Dermatitis—Mitoxantrone—prostate cancer	1.47e-05	0.000217	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.47e-05	0.000217	CcSEcCtD
Thiotepa—Headache—Mitoxantrone—prostate cancer	1.46e-05	0.000215	CcSEcCtD
Thiotepa—Arthralgia—Prednisone—prostate cancer	1.45e-05	0.000214	CcSEcCtD
Thiotepa—Myalgia—Prednisone—prostate cancer	1.45e-05	0.000214	CcSEcCtD
Thiotepa—Paraesthesia—Docetaxel—prostate cancer	1.45e-05	0.000213	CcSEcCtD
Thiotepa—Anxiety—Prednisone—prostate cancer	1.45e-05	0.000213	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.44e-05	0.000212	CcSEcCtD
Thiotepa—Somnolence—Docetaxel—prostate cancer	1.44e-05	0.000211	CcSEcCtD
Thiotepa—Eye disorder—Epirubicin—prostate cancer	1.43e-05	0.000211	CcSEcCtD
Thiotepa—Hypersensitivity—Etoposide—prostate cancer	1.43e-05	0.000211	CcSEcCtD
Thiotepa—Tinnitus—Epirubicin—prostate cancer	1.43e-05	0.00021	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—prostate cancer	1.43e-05	0.00021	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.43e-05	0.00021	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—prostate cancer	1.42e-05	0.000209	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—prostate cancer	1.42e-05	0.000209	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—prostate cancer	1.42e-05	0.000209	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.41e-05	0.000665	CbGpPWpGaD
Thiotepa—Paraesthesia—Capecitabine—prostate cancer	1.41e-05	0.000207	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—prostate cancer	1.4e-05	0.000207	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—prostate cancer	1.4e-05	0.000206	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.4e-05	0.000658	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Docetaxel—prostate cancer	1.4e-05	0.000205	CcSEcCtD
Thiotepa—Asthenia—Etoposide—prostate cancer	1.4e-05	0.000205	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—prostate cancer	1.4e-05	0.000205	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—prostate cancer	1.39e-05	0.000205	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.39e-05	0.000656	CbGpPWpGaD
Thiotepa—Angiopathy—Epirubicin—prostate cancer	1.39e-05	0.000205	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—prostate cancer	1.39e-05	0.000205	CcSEcCtD
Thiotepa—Nausea—Mitoxantrone—prostate cancer	1.39e-05	0.000204	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—prostate cancer	1.39e-05	0.000204	CcSEcCtD
Thiotepa—Infection—Prednisone—prostate cancer	1.38e-05	0.000204	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—prostate cancer	1.38e-05	0.000203	CcSEcCtD
Thiotepa—Constipation—Docetaxel—prostate cancer	1.38e-05	0.000203	CcSEcCtD
Thiotepa—Pain—Docetaxel—prostate cancer	1.38e-05	0.000203	CcSEcCtD
Thiotepa—Dyspepsia—Capecitabine—prostate cancer	1.38e-05	0.000203	CcSEcCtD
Thiotepa—Chills—Epirubicin—prostate cancer	1.38e-05	0.000203	CcSEcCtD
Thiotepa—Pruritus—Etoposide—prostate cancer	1.38e-05	0.000202	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—prostate cancer	1.37e-05	0.000202	CcSEcCtD
Thiotepa—Nervous system disorder—Prednisone—prostate cancer	1.37e-05	0.000201	CcSEcCtD
Thiotepa—Tachycardia—Prednisone—prostate cancer	1.36e-05	0.0002	CcSEcCtD
Thiotepa—Decreased appetite—Capecitabine—prostate cancer	1.36e-05	0.0002	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—prostate cancer	1.36e-05	0.000199	CcSEcCtD
Thiotepa—Skin disorder—Prednisone—prostate cancer	1.35e-05	0.000199	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Capecitabine—prostate cancer	1.35e-05	0.000199	CcSEcCtD
Thiotepa—Fatigue—Capecitabine—prostate cancer	1.35e-05	0.000198	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—prostate cancer	1.34e-05	0.000198	CcSEcCtD
Thiotepa—Constipation—Capecitabine—prostate cancer	1.34e-05	0.000197	CcSEcCtD
Thiotepa—Pain—Capecitabine—prostate cancer	1.34e-05	0.000197	CcSEcCtD
Thiotepa—Erythema—Epirubicin—prostate cancer	1.34e-05	0.000196	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—prostate cancer	1.34e-05	0.000196	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—prostate cancer	1.33e-05	0.000196	CcSEcCtD
Thiotepa—Diarrhoea—Etoposide—prostate cancer	1.33e-05	0.000196	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.33e-05	0.000626	CbGpPWpGaD
Thiotepa—Anorexia—Prednisone—prostate cancer	1.33e-05	0.000195	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—prostate cancer	1.33e-05	0.000195	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—prostate cancer	1.32e-05	0.000195	CcSEcCtD
Thiotepa—Gastrointestinal pain—Docetaxel—prostate cancer	1.32e-05	0.000194	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—prostate cancer	1.32e-05	0.000194	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADI1—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSAT1—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TST—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CBR1—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CSAD—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GRHL1—prostate cancer	1.31e-05	0.000619	CbGpPWpGaD
Thiotepa—Tension—Epirubicin—prostate cancer	1.31e-05	0.000193	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—prostate cancer	1.3e-05	0.000191	CcSEcCtD
Thiotepa—Back pain—Epirubicin—prostate cancer	1.29e-05	0.00019	CcSEcCtD
Thiotepa—Feeling abnormal—Capecitabine—prostate cancer	1.29e-05	0.00019	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—prostate cancer	1.29e-05	0.000189	CcSEcCtD
Thiotepa—Dizziness—Etoposide—prostate cancer	1.29e-05	0.000189	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—prostate cancer	1.28e-05	0.000189	CcSEcCtD
Thiotepa—Gastrointestinal pain—Capecitabine—prostate cancer	1.28e-05	0.000188	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—prostate cancer	1.28e-05	0.000188	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—prostate cancer	1.28e-05	0.000188	CcSEcCtD
Thiotepa—Abdominal pain—Docetaxel—prostate cancer	1.28e-05	0.000188	CcSEcCtD
Thiotepa—Chills—Doxorubicin—prostate cancer	1.27e-05	0.000187	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Prednisone—prostate cancer	1.27e-05	0.000187	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—prostate cancer	1.27e-05	0.000187	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—HPGDS—prostate cancer	1.27e-05	0.000597	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.26e-05	0.000593	CbGpPWpGaD
Thiotepa—Vision blurred—Epirubicin—prostate cancer	1.26e-05	0.000185	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—prostate cancer	1.25e-05	0.000185	CcSEcCtD
Thiotepa—Paraesthesia—Prednisone—prostate cancer	1.25e-05	0.000184	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—prostate cancer	1.24e-05	0.000183	CcSEcCtD
Thiotepa—Urticaria—Capecitabine—prostate cancer	1.24e-05	0.000183	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.24e-05	0.000585	CbGpPWpGaD
Thiotepa—Abdominal pain—Capecitabine—prostate cancer	1.24e-05	0.000182	CcSEcCtD
Thiotepa—Body temperature increased—Capecitabine—prostate cancer	1.24e-05	0.000182	CcSEcCtD
Thiotepa—Vomiting—Etoposide—prostate cancer	1.24e-05	0.000182	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—prostate cancer	1.24e-05	0.000182	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—prostate cancer	1.24e-05	0.000182	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—prostate cancer	1.23e-05	0.000182	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.23e-05	0.000579	CbGpPWpGaD
Thiotepa—Agitation—Epirubicin—prostate cancer	1.23e-05	0.000181	CcSEcCtD
Thiotepa—Dyspepsia—Prednisone—prostate cancer	1.23e-05	0.00018	CcSEcCtD
Thiotepa—Rash—Etoposide—prostate cancer	1.23e-05	0.00018	CcSEcCtD
Thiotepa—Dermatitis—Etoposide—prostate cancer	1.23e-05	0.00018	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—UGT2B15—prostate cancer	1.22e-05	0.000575	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UGT2B17—prostate cancer	1.22e-05	0.000575	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GRHPR—prostate cancer	1.22e-05	0.000575	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CKMT2—prostate cancer	1.22e-05	0.000575	CbGpPWpGaD
Thiotepa—Headache—Etoposide—prostate cancer	1.22e-05	0.000179	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.21e-05	0.000572	CbGpPWpGaD
Thiotepa—Tension—Doxorubicin—prostate cancer	1.21e-05	0.000178	CcSEcCtD
Thiotepa—Decreased appetite—Prednisone—prostate cancer	1.21e-05	0.000178	CcSEcCtD
Thiotepa—Fatigue—Prednisone—prostate cancer	1.2e-05	0.000177	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—prostate cancer	1.2e-05	0.000177	CcSEcCtD
Thiotepa—Leukopenia—Epirubicin—prostate cancer	1.2e-05	0.000176	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—prostate cancer	1.2e-05	0.000176	CcSEcCtD
Thiotepa—Constipation—Prednisone—prostate cancer	1.19e-05	0.000175	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—prostate cancer	1.19e-05	0.000175	CcSEcCtD
Thiotepa—Cough—Epirubicin—prostate cancer	1.17e-05	0.000171	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	1.17e-05	0.000549	CbGpPWpGaD
Thiotepa—Vision blurred—Doxorubicin—prostate cancer	1.16e-05	0.000171	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	1.16e-05	0.000548	CbGpPWpGaD
Thiotepa—Asthenia—Docetaxel—prostate cancer	1.16e-05	0.000171	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—prostate cancer	1.16e-05	0.00017	CcSEcCtD
Thiotepa—Nausea—Etoposide—prostate cancer	1.16e-05	0.00017	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—prostate cancer	1.15e-05	0.00017	CcSEcCtD
Thiotepa—Hypersensitivity—Capecitabine—prostate cancer	1.15e-05	0.00017	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisone—prostate cancer	1.15e-05	0.000169	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—NAGLU—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—RFK—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SULT2B1—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MBTPS1—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM3—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PGAM2—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AOX1—prostate cancer	1.15e-05	0.000541	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	1.15e-05	0.00054	CbGpPWpGaD
Thiotepa—Pruritus—Docetaxel—prostate cancer	1.14e-05	0.000168	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—prostate cancer	1.14e-05	0.000168	CcSEcCtD
Thiotepa—Gastrointestinal pain—Prednisone—prostate cancer	1.14e-05	0.000168	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—prostate cancer	1.14e-05	0.000167	CcSEcCtD
Thiotepa—Arthralgia—Epirubicin—prostate cancer	1.14e-05	0.000167	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—prostate cancer	1.14e-05	0.000167	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—prostate cancer	1.13e-05	0.000167	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.13e-05	0.000166	CcSEcCtD
Thiotepa—Asthenia—Capecitabine—prostate cancer	1.12e-05	0.000165	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—NCOA2—prostate cancer	1.11e-05	0.000522	CbGpPWpGaD
Thiotepa—Urticaria—Prednisone—prostate cancer	1.11e-05	0.000163	CcSEcCtD
Thiotepa—Pruritus—Capecitabine—prostate cancer	1.11e-05	0.000163	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—prostate cancer	1.11e-05	0.000163	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—prostate cancer	1.11e-05	0.000163	CcSEcCtD
Thiotepa—Body temperature increased—Prednisone—prostate cancer	1.1e-05	0.000162	CcSEcCtD
Thiotepa—Abdominal pain—Prednisone—prostate cancer	1.1e-05	0.000162	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—prostate cancer	1.1e-05	0.000162	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—AMACR—prostate cancer	1.09e-05	0.000513	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP3A43—prostate cancer	1.09e-05	0.000513	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—DEGS1—prostate cancer	1.09e-05	0.000513	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NAT1—prostate cancer	1.09e-05	0.000513	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SRD5A2—prostate cancer	1.09e-05	0.000513	CbGpPWpGaD
Thiotepa—Infection—Epirubicin—prostate cancer	1.08e-05	0.000159	CcSEcCtD
Thiotepa—Cough—Doxorubicin—prostate cancer	1.08e-05	0.000159	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—prostate cancer	1.07e-05	0.000158	CcSEcCtD
Thiotepa—Diarrhoea—Capecitabine—prostate cancer	1.07e-05	0.000157	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—prostate cancer	1.07e-05	0.000157	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—prostate cancer	1.07e-05	0.000157	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—prostate cancer	1.07e-05	0.000157	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—prostate cancer	1.07e-05	0.000157	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—prostate cancer	1.06e-05	0.000157	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—prostate cancer	1.06e-05	0.000156	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—prostate cancer	1.05e-05	0.000155	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—prostate cancer	1.05e-05	0.000155	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—prostate cancer	1.05e-05	0.000154	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.04e-05	0.000154	CcSEcCtD
Thiotepa—Anorexia—Epirubicin—prostate cancer	1.04e-05	0.000153	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—HSD17B1—prostate cancer	1.04e-05	0.000489	CbGpPWpGaD
Thiotepa—Dizziness—Capecitabine—prostate cancer	1.03e-05	0.000152	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	1.03e-05	0.000487	CbGpPWpGaD
Thiotepa—Vomiting—Docetaxel—prostate cancer	1.03e-05	0.000151	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisone—prostate cancer	1.03e-05	0.000151	CcSEcCtD
Thiotepa—Rash—Docetaxel—prostate cancer	1.02e-05	0.00015	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	1.02e-05	0.00048	CbGpPWpGaD
Thiotepa—Dermatitis—Docetaxel—prostate cancer	1.02e-05	0.00015	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—prostate cancer	1.02e-05	0.00015	CcSEcCtD
Thiotepa—Headache—Docetaxel—prostate cancer	1.01e-05	0.000149	CcSEcCtD
Thiotepa—Infection—Doxorubicin—prostate cancer	1e-05	0.000147	CcSEcCtD
Thiotepa—Asthenia—Prednisone—prostate cancer	1e-05	0.000147	CcSEcCtD
Thiotepa—Vomiting—Capecitabine—prostate cancer	9.95e-06	0.000146	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Epirubicin—prostate cancer	9.93e-06	0.000146	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—prostate cancer	9.89e-06	0.000146	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—prostate cancer	9.88e-06	0.000145	CcSEcCtD
Thiotepa—Rash—Capecitabine—prostate cancer	9.87e-06	0.000145	CcSEcCtD
Thiotepa—Pruritus—Prednisone—prostate cancer	9.86e-06	0.000145	CcSEcCtD
Thiotepa—Dermatitis—Capecitabine—prostate cancer	9.86e-06	0.000145	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—prostate cancer	9.84e-06	0.000145	CcSEcCtD
Thiotepa—Headache—Capecitabine—prostate cancer	9.8e-06	0.000144	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—prostate cancer	9.8e-06	0.000144	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	9.79e-06	0.000461	CbGpPWpGaD
Thiotepa—Paraesthesia—Epirubicin—prostate cancer	9.79e-06	0.000144	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—prostate cancer	9.69e-06	0.000143	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	9.66e-06	0.000455	CbGpPWpGaD
Thiotepa—Anorexia—Doxorubicin—prostate cancer	9.61e-06	0.000141	CcSEcCtD
Thiotepa—Nausea—Docetaxel—prostate cancer	9.6e-06	0.000141	CcSEcCtD
Thiotepa—Dyspepsia—Epirubicin—prostate cancer	9.6e-06	0.000141	CcSEcCtD
Thiotepa—Diarrhoea—Prednisone—prostate cancer	9.54e-06	0.00014	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GGT1—prostate cancer	9.48e-06	0.000447	CbGpPWpGaD
Thiotepa—Decreased appetite—Epirubicin—prostate cancer	9.48e-06	0.000139	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Epirubicin—prostate cancer	9.41e-06	0.000138	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—prostate cancer	9.4e-06	0.000138	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—NCOA1—prostate cancer	9.34e-06	0.00044	CbGpPWpGaD
Thiotepa—Pain—Epirubicin—prostate cancer	9.32e-06	0.000137	CcSEcCtD
Thiotepa—Constipation—Epirubicin—prostate cancer	9.32e-06	0.000137	CcSEcCtD
Thiotepa—Nausea—Capecitabine—prostate cancer	9.29e-06	0.000137	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—B4GALT4—prostate cancer	9.26e-06	0.000436	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPGD—prostate cancer	9.26e-06	0.000436	CbGpPWpGaD
Thiotepa—Dizziness—Prednisone—prostate cancer	9.22e-06	0.000136	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	9.21e-06	0.000434	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.19e-06	0.000135	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	9.08e-06	0.000428	CbGpPWpGaD
Thiotepa—Paraesthesia—Doxorubicin—prostate cancer	9.06e-06	0.000133	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—prostate cancer	8.98e-06	0.000132	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—prostate cancer	8.97e-06	0.000132	CcSEcCtD
Thiotepa—Gastrointestinal pain—Epirubicin—prostate cancer	8.91e-06	0.000131	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—RXRA—prostate cancer	8.88e-06	0.000419	CbGpPWpGaD
Thiotepa—Dyspepsia—Doxorubicin—prostate cancer	8.88e-06	0.000131	CcSEcCtD
Thiotepa—Vomiting—Prednisone—prostate cancer	8.86e-06	0.00013	CcSEcCtD
Thiotepa—Rash—Prednisone—prostate cancer	8.79e-06	0.000129	CcSEcCtD
Thiotepa—Dermatitis—Prednisone—prostate cancer	8.78e-06	0.000129	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—prostate cancer	8.77e-06	0.000129	CcSEcCtD
Thiotepa—Headache—Prednisone—prostate cancer	8.73e-06	0.000128	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.71e-06	0.000128	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—TNFRSF21—prostate cancer	8.7e-06	0.00041	CbGpPWpGaD
Thiotepa—Fatigue—Doxorubicin—prostate cancer	8.7e-06	0.000128	CcSEcCtD
Thiotepa—Urticaria—Epirubicin—prostate cancer	8.66e-06	0.000127	CcSEcCtD
Thiotepa—Pain—Doxorubicin—prostate cancer	8.63e-06	0.000127	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—prostate cancer	8.63e-06	0.000127	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—prostate cancer	8.62e-06	0.000127	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—prostate cancer	8.62e-06	0.000127	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—COMT—prostate cancer	8.56e-06	0.000403	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTP1—prostate cancer	8.52e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTAP—prostate cancer	8.47e-06	0.000399	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP7B1—prostate cancer	8.47e-06	0.000399	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	8.44e-06	0.000398	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	8.4e-06	0.000396	CbGpPWpGaD
Thiotepa—Feeling abnormal—Doxorubicin—prostate cancer	8.31e-06	0.000122	CcSEcCtD
Thiotepa—Nausea—Prednisone—prostate cancer	8.28e-06	0.000122	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—SULT1E1—prostate cancer	8.25e-06	0.000389	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SRD5A1—prostate cancer	8.25e-06	0.000389	CbGpPWpGaD
Thiotepa—Gastrointestinal pain—Doxorubicin—prostate cancer	8.25e-06	0.000121	CcSEcCtD
Thiotepa—Hypersensitivity—Epirubicin—prostate cancer	8.03e-06	0.000118	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—prostate cancer	8.01e-06	0.000118	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—prostate cancer	7.97e-06	0.000117	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—prostate cancer	7.97e-06	0.000117	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—ACSL4—prostate cancer	7.87e-06	0.000371	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSD17B3—prostate cancer	7.87e-06	0.000371	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.83e-06	0.000369	CbGpPWpGaD
Thiotepa—Asthenia—Epirubicin—prostate cancer	7.82e-06	0.000115	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.72e-06	0.000364	CbGpPWpGaD
Thiotepa—Pruritus—Epirubicin—prostate cancer	7.71e-06	0.000113	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—PHGDH—prostate cancer	7.54e-06	0.000355	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UMPS—prostate cancer	7.54e-06	0.000355	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ARG2—prostate cancer	7.54e-06	0.000355	CbGpPWpGaD
Thiotepa—Diarrhoea—Epirubicin—prostate cancer	7.46e-06	0.00011	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—prostate cancer	7.43e-06	0.000109	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	7.42e-06	0.00035	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LDHB—prostate cancer	7.4e-06	0.000349	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HAO1—prostate cancer	7.32e-06	0.000345	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	7.32e-06	0.000345	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP3A5—prostate cancer	7.26e-06	0.000342	CbGpPWpGaD
Thiotepa—Asthenia—Doxorubicin—prostate cancer	7.24e-06	0.000106	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—prostate cancer	7.21e-06	0.000106	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—prostate cancer	7.14e-06	0.000105	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—PDHA1—prostate cancer	7.01e-06	0.00033	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TCN2—prostate cancer	7.01e-06	0.00033	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UCP3—prostate cancer	7.01e-06	0.00033	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA3—prostate cancer	7.01e-06	0.00033	CbGpPWpGaD
Thiotepa—Vomiting—Epirubicin—prostate cancer	6.93e-06	0.000102	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—prostate cancer	6.9e-06	0.000102	CcSEcCtD
Thiotepa—Rash—Epirubicin—prostate cancer	6.87e-06	0.000101	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—prostate cancer	6.87e-06	0.000101	CcSEcCtD
Thiotepa—Headache—Epirubicin—prostate cancer	6.83e-06	0.0001	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—HSD3B1—prostate cancer	6.69e-06	0.000315	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC22A3—prostate cancer	6.69e-06	0.000315	CbGpPWpGaD
Thiotepa—Dizziness—Doxorubicin—prostate cancer	6.67e-06	9.81e-05	CcSEcCtD
Thiotepa—Nausea—Epirubicin—prostate cancer	6.47e-06	9.53e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—GSTA4—prostate cancer	6.42e-06	0.000302	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TBXAS1—prostate cancer	6.42e-06	0.000302	CbGpPWpGaD
Thiotepa—Vomiting—Doxorubicin—prostate cancer	6.41e-06	9.43e-05	CcSEcCtD
Thiotepa—Rash—Doxorubicin—prostate cancer	6.36e-06	9.36e-05	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—prostate cancer	6.35e-06	9.35e-05	CcSEcCtD
Thiotepa—Headache—Doxorubicin—prostate cancer	6.32e-06	9.3e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—GSTA2—prostate cancer	6.25e-06	0.000295	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SULT1A1—prostate cancer	6.18e-06	0.000291	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCG5—prostate cancer	6.18e-06	0.000291	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA1—prostate cancer	6.03e-06	0.000284	CbGpPWpGaD
Thiotepa—Nausea—Doxorubicin—prostate cancer	5.99e-06	8.81e-05	CcSEcCtD
Thiotepa—CYP3A4—Metabolism—CBR1—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CSAD—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADI1—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GRHL1—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSAT1—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TST—prostate cancer	5.97e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTO1—prostate cancer	5.96e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSD3B2—prostate cancer	5.96e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NAT2—prostate cancer	5.96e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PLCB2—prostate cancer	5.72e-06	0.000269	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2C18—prostate cancer	5.72e-06	0.000269	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LRP2—prostate cancer	5.72e-06	0.000269	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—P4HB—prostate cancer	5.61e-06	0.000264	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.55e-06	0.000261	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CKMT2—prostate cancer	5.55e-06	0.000261	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.55e-06	0.000261	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GRHPR—prostate cancer	5.55e-06	0.000261	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC22A1—prostate cancer	5.45e-06	0.000257	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SULT2A1—prostate cancer	5.32e-06	0.00025	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MED12—prostate cancer	5.23e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—RFK—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM3—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MBTPS1—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAGLU—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PGAM2—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AOX1—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SULT2B1—prostate cancer	5.22e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GNG5—prostate cancer	5.19e-06	0.000244	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA3—prostate cancer	5e-06	0.000235	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—DEGS1—prostate cancer	4.95e-06	0.000233	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AMACR—prostate cancer	4.95e-06	0.000233	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.95e-06	0.000233	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAT1—prostate cancer	4.95e-06	0.000233	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.95e-06	0.000233	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPGDS—prostate cancer	4.77e-06	0.000225	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2C19—prostate cancer	4.74e-06	0.000223	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.72e-06	0.000222	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTT1—prostate cancer	4.62e-06	0.000218	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ACHE—prostate cancer	4.62e-06	0.000218	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2A6—prostate cancer	4.57e-06	0.000215	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKR1C3—prostate cancer	4.45e-06	0.000209	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PRKACB—prostate cancer	4.42e-06	0.000208	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP17A1—prostate cancer	4.38e-06	0.000206	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.21e-06	0.000198	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPGD—prostate cancer	4.21e-06	0.000198	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA2—prostate cancer	4.17e-06	0.000197	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC5A5—prostate cancer	3.98e-06	0.000187	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.95e-06	0.000186	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2E1—prostate cancer	3.89e-06	0.000183	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.85e-06	0.000181	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTAP—prostate cancer	3.85e-06	0.000181	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NQO1—prostate cancer	3.84e-06	0.000181	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TH—prostate cancer	3.79e-06	0.000178	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.75e-06	0.000177	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.75e-06	0.000177	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP3A4—prostate cancer	3.75e-06	0.000177	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1B1—prostate cancer	3.68e-06	0.000174	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ACSL4—prostate cancer	3.58e-06	0.000168	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.58e-06	0.000168	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GGT1—prostate cancer	3.57e-06	0.000168	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA1—prostate cancer	3.52e-06	0.000166	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP19A1—prostate cancer	3.46e-06	0.000163	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PHGDH—prostate cancer	3.43e-06	0.000162	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UMPS—prostate cancer	3.43e-06	0.000162	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ARG2—prostate cancer	3.43e-06	0.000162	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LDHB—prostate cancer	3.36e-06	0.000158	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—RXRA—prostate cancer	3.34e-06	0.000158	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.3e-06	0.000155	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—COMT—prostate cancer	3.22e-06	0.000152	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTP1—prostate cancer	3.21e-06	0.000151	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PDHA1—prostate cancer	3.19e-06	0.00015	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UCP3—prostate cancer	3.19e-06	0.00015	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TCN2—prostate cancer	3.19e-06	0.00015	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA3—prostate cancer	3.19e-06	0.00015	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ITPR1—prostate cancer	3.15e-06	0.000149	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.04e-06	0.000143	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.04e-06	0.000143	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TYMS—prostate cancer	2.98e-06	0.00014	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—prostate cancer	2.95e-06	0.000139	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.92e-06	0.000137	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA4—prostate cancer	2.92e-06	0.000137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LPL—prostate cancer	2.89e-06	0.000136	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA2—prostate cancer	2.84e-06	0.000134	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.81e-06	0.000132	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCG5—prostate cancer	2.81e-06	0.000132	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A1—prostate cancer	2.79e-06	0.000132	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ERCC2—prostate cancer	2.77e-06	0.00013	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA1—prostate cancer	2.74e-06	0.000129	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.71e-06	0.000128	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAT2—prostate cancer	2.71e-06	0.000128	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTO1—prostate cancer	2.71e-06	0.000128	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTHFR—prostate cancer	2.6e-06	0.000123	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LRP2—prostate cancer	2.6e-06	0.000122	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PLCB2—prostate cancer	2.6e-06	0.000122	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.6e-06	0.000122	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARA—prostate cancer	2.55e-06	0.00012	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—P4HB—prostate cancer	2.55e-06	0.00012	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.48e-06	0.000117	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.42e-06	0.000114	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CAV1—prostate cancer	2.4e-06	0.000113	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MED12—prostate cancer	2.38e-06	0.000112	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GNG5—prostate cancer	2.36e-06	0.000111	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA3—prostate cancer	2.27e-06	0.000107	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.19e-06	0.000103	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPGDS—prostate cancer	2.17e-06	0.000102	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.15e-06	0.000101	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTT1—prostate cancer	2.1e-06	9.9e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ACHE—prostate cancer	2.1e-06	9.9e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.08e-06	9.79e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—INS—prostate cancer	2.07e-06	9.75e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CREBBP—prostate cancer	2.03e-06	9.55e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.02e-06	9.52e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PRKACB—prostate cancer	2.01e-06	9.47e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.99e-06	9.37e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.92e-06	9.06e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA2—prostate cancer	1.9e-06	8.93e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NOS3—prostate cancer	1.82e-06	8.55e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.81e-06	8.52e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.77e-06	8.32e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NQO1—prostate cancer	1.75e-06	8.23e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TH—prostate cancer	1.72e-06	8.11e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.68e-06	7.9e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.67e-06	7.89e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS2—prostate cancer	1.66e-06	7.82e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GGT1—prostate cancer	1.62e-06	7.64e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA1—prostate cancer	1.6e-06	7.52e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.57e-06	7.42e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—RXRA—prostate cancer	1.52e-06	7.16e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—COMT—prostate cancer	1.46e-06	6.89e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTP1—prostate cancer	1.46e-06	6.86e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTEN—prostate cancer	1.45e-06	6.82e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ITPR1—prostate cancer	1.43e-06	6.75e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—EP300—prostate cancer	1.38e-06	6.51e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TYMS—prostate cancer	1.35e-06	6.38e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—prostate cancer	1.34e-06	6.31e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LPL—prostate cancer	1.31e-06	6.19e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.27e-06	5.98e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ERCC2—prostate cancer	1.26e-06	5.93e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTHFR—prostate cancer	1.18e-06	5.57e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARA—prostate cancer	1.16e-06	5.47e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CAV1—prostate cancer	1.09e-06	5.14e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.02e-06	4.81e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.94e-07	4.68e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—INS—prostate cancer	9.41e-07	4.43e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CREBBP—prostate cancer	9.22e-07	4.34e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.74e-07	4.12e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKT1—prostate cancer	8.35e-07	3.93e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NOS3—prostate cancer	8.25e-07	3.89e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.62e-07	3.59e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS2—prostate cancer	7.55e-07	3.55e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTEN—prostate cancer	6.58e-07	3.1e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—EP300—prostate cancer	6.28e-07	2.96e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.64e-07	2.19e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKT1—prostate cancer	3.79e-07	1.79e-05	CbGpPWpGaD
